Dr. Santhosh Ambika, MD

Dr. Ambika practices at Cancer Care Specialists in Reno, Nevada.

Dr. Ambika's NPI, 1174747323, was assigned on April 12, 2007. Dr. Ambika graduated from University of Kerala Medical College in 2001. Dr. Ambika holds Nevada license 16308.

Dr. Ambika's primary practice is Cancer Care Specialists, at 5423 Reno Corporate Dr, Reno, NV 89511 in Washoe County. The practice phone is (775) 329-0873.

Dr. Ambika's primary practice is Cancer Care Specialists in Reno, Nevada. Dr. Ambika is also affiliated with Renown Regional Medical Center. The medical group on file is Cancer Care Specialists. Dmand AI also links Dr. Ambika to 4 more hospitals and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Ambika practices, 6 sites in all. Vendor and product names are available with a free account.

Hematology and oncology is Dr. Ambika's primary specialty in the NPI Registry, under taxonomy code 207RH0003X. Dr. Ambika is board certified in hematology by the American Board of Internal Medicine. Dmand AI has Dr. Ambika's licenses on file in 3 states: Nevada, Virginia and Massachusetts.

Dmand AI lists breast cancer, chronic anemia, chronic leukemia, colorectal cancer, fluid and electrolyte imbalances, immune deficiency disease, lung cancer and lymphoma among the conditions Dr. Ambika treats.

CMS data shows 84,288 Medicare services from Dr. Ambika across 61 procedure codes in 2024, for 770 Medicare patients. Medicare paid $1,943,146 for them.

CMS counts 770 Medicare patients who saw Dr. Ambika in 2024. The largest group is 65 to 74, with 368 patients. 72% of them have high cholesterol, and 71% have high blood pressure. 6% are also on Medicaid. Their average risk score is 2.23, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Ambika's median patient age at 71, with 53% women.

In 2024, Dr. Ambika wrote 1,354 Medicare Part D claims for 280 patients. 65% of them were for generic drugs. CMS names the drug for 998 of them, across 32 drugs with 11 or more claims each, at $3,950,170 in total drug cost. In 2023, CMS named 983 claims across 34 drugs.

Dr. Ambika accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Ambika as offering telehealth.

Dmand AI links 7 papers to Dr. Ambika, published from 2018 to 2019. 2018 was the busiest year, with 3. The most frequent topics are SEER Program. Dr. Ambika's most frequent co-authors are Mark Bilinyi Ulanja, MD, Bryce David Beutler and Mohamed E. Taha, MD.

CMS Open Payments shows 521 general payments to Dr. Ambika from 75 drug and device companies from 2016 to 2025. Consulting fees make up the largest share, 49% of the total. Abbvie Inc. paid the most, $46,100.

Dr. Ambika graduated from University of Kerala Medical College in 2001.

Dr. Ambika is in network with 16 carriers, including United Healthcare, Elevance and HCSC. PPO plans come from the most carriers, 8. Check the plan with the practice before a visit.